Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.2565
-0.0125 (-4.65%)
Feb 3, 2026, 2:19 PM EST - Market open
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $18.86 million as of February 3, 2026. Its market cap has increased by 110.21% in one year.
Market Cap
18.86M
Enterprise Value
11.57M
1-Year Change
110.21%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $18.86M, a decrease of -85.19%. That is a compound annual growth rate of -39.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 19.78M | -5.64% |
| Dec 31, 2025 | 20.96M | 103.27% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 21.62M |
| CASI Pharmaceuticals | 20.96M |
| IO Biotech | 20.87M |
| NanoViricides | 20.81M |
| Pasithea Therapeutics | 19.88M |
| Lexaria Bioscience | 19.50M |
| IN8bio | 19.24M |
| VYNE Therapeutics | 18.84M |